AVITA Medical (RCEL) Capital Leases (2018 - 2019)
AVITA Medical posted quarterly Capital Leases of $3415.9 for Q4 2019, down 90.97% on a QoQ basis from $37825.5 in Q2 2019.
AVITA Medical (RCEL) has 2 years of Capital Leases data on file, last reported at $3415.9 in Q4 2019.
- For the quarter ending Q4 2019, Capital Leases changed N/A year-over-year to $3415.9; the trailing twelve-month figure through Dec 2019 stood at $3415.9 (changed N/A YoY), and the FY2019 full-year result was $3415.9, changed N/A from the prior year.
- Capital Leases for Q4 2019 stood at $3415.9, down from $37825.5 in the prior quarter.
- Across five years, Capital Leases topped out at $101698.8 in Q2 2018 and bottomed at $3415.9 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3,415.94 |
| Jun 30, 2019 | 37,825.50 |
| Jun 30, 2018 | 101,698.83 |